| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |